Compare Moderna, Inc. (MRNA) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs OneSpan Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while OneSpan Inc trades at $15.37 (market cap $575.37M). The key difference: Moderna, Inc. is far larger — about 41× OneSpan Inc's market cap, and OneSpan Inc pays a 3.35% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | OSPN | |
|---|---|---|
Market Cap | $23.60B | $575.37M |
Sector | Health | Technology |
52-Week High | $81.80 | $16.32 |
52-Week Low | $22.36 | $10.15 |
Enterprise Value | $19.70B | $533.57M |
Dividend Yield | — | 3.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
